Fight against 'Relapsing' malaria gets new weapon in PNG trial
NCT ID NCT05874271
Summary
This study tested a new way to treat a type of malaria that can hide in the liver and cause people to get sick again. Researchers gave patients a higher dose of an existing drug (primaquine) over a shorter time, but first checked them for a genetic condition that makes the drug risky. The goal was to see if this faster treatment is safe, works well, and can be practically used in local health clinics in Papua New Guinea.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VIVAX MALARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baro Clinic
Vanimo, Sandaun Province, Papua New Guinea
-
Mugil Health Centre
Madang, Madang Province, Papua New Guinea
-
Napapar Health Centre
Kokopo, East New Britain Province, Papua New Guinea
-
Wirui Clinic
Wewak, East Sepik Province, Papua New Guinea
Conditions
Explore the condition pages connected to this study.